Regulatory29 Aug 2026, 03:01 pm
Sudarshan Pharma Files FY26 Annual Report
AI Summary
Sudarshan Pharma Industries Ltd has filed its Annual Report for the Financial Year 2025-26, in compliance with Regulation 34 of SEBI Listing Regulations. The report is being disseminated electronically to shareholders. It includes sections on Corporate Overview, Statutory Reports, Financial Statements (Standalone and Consolidated), and details of the Board of Directors and key management personnel. The company also included a forward-looking statements disclaimer.
Key Highlights
- Annual Report for FY 2025-26 filed with regulators.
- Report disseminated electronically to shareholders.
- Includes standalone and consolidated financial statements.
- Details corporate information, board, and management.
- Contains forward-looking statements disclaimer.
Price Impact
More from SUDARSHAN